Clue Cards

Concise summaries of key terms, topics, or policies for subscribers on pharma, biotech, business, and policy.


Our team is known for policy analysis, particularly evidence-based analysis, which we publish as inferences.


Deep dives into topics on pharmaceutical policies, regulations, and economics in biotech


Stay up to date with the latest biotech data analytic news


CMS issued final guidance on the Identification of Selected Drugs for Initial Price Applicability Year 2026

The Department of Health and Human Services Centers for Medicare and Medicaid Services (CMS) recently released initial g...


Top 20 Medicare Part B Drug Price Trends

This article will focus on the role of Part B drug prices and how they have changed over time.


Qualia Bio Announces Acquisition by BluePath Solutions

BluePath Solutions, a leading health economics and value communication consulting firm, has acquired Qualia Bio.


Medicare Part B Market Landscape

Our landscape report provides a high-level overview of the Part B program and offers clients a comprehensive review of k...


National Average MS-DRG Payment Estimates FY2023 & FY2024

The national average payment for each MS-DRG is calculated by multiplying the fiscal year relative weight of the MS-DRG ...

Filter By Type


Showing 10 of 10